Morepen Laboratories Ltd., incorporated in the year 1984, is a Mid Cap company (having a market cap of Rs 1275.26 Cr.) operating in Pharmaceuticals and health care sector.
Morepen Laboratories Ltd. key Products/Revenue Segments include API Chemicals which contributed Rs 216.06 Cr to Sales Value (58.35% of Total Sales), Tablets which contributed Rs 52.30 Cr to Sales Value (14.12% of Total Sales), Home Care which contributed Rs 51.31 Cr to Sales Value (13.85% of Total Sales), Syrups which contributed Rs 14.47 Cr to Sales Value (3.90% of Total Sales), Other Operating Revenue which contributed Rs 12.00 Cr to Sales Value (3.24% of Total Sales), Others which contributed Rs 10.88 Cr to Sales Value (2.93% of Total Sales),
Capsules which contributed Rs 9.57 Cr to Sales Value (2.58% of Total Sales), Export Incentives which contributed Rs 3.67 Cr to Sales Value (0.99% of Total Sales), for the year ending 31-Mar-2015.
Capsules which contributed Rs 9.57 Cr to Sales Value (2.58% of Total Sales), Export Incentives which contributed Rs 3.67 Cr to Sales Value (0.99% of Total Sales), for the year ending 31-Mar-2015.
For the quarter ended 30-Sep-2015, the company has reported a Standalone sales of Rs. 108.92 Cr., up 9.72% from last quarter Sales of Rs. 99.28 Cr. and up 24.62% from last year same quarter Sales of Rs. 87.40 Cr. Company has reported net profit after tax of Rs. 3.22 Cr. in latest quarter.
The company’s management includes Mr.Thomas P Joshua, Mr.Ajay Sharma, Mr.Thomas P Joshua, Dr.Arun Kumar Sinha, Mr.Bhupender Raj Wadhwa, Mr.Manoj Joshi, Mr.Sukhcharan Singh, Mr.Sushil Suri, Ms.Archana Bhargava.
Company has M Kamal Mahajan & Co. as its auditors. As on 30-Sep-2015, the company has a total of 449,826,203 shares outstanding.
No comments:
Post a Comment